Related Experiment Video
Updated: May 16, 2026

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
FAK is a critical regulator of neuroblastoma liver metastasis
Sora Lee1, Jingbo Qiao, Pritha Paul
1Departments of Pediatric Surgery, Vanderbilt University Medical Center1, Nashville, TN, USA.
Abstract:
Neuroblastomas express increased levels of gastrin-releasing peptide receptor (GRP-R). However, the exact molecular mechanisms involved in GRP-R-mediated cell signaling in neuroblastoma growth and metastasis are unknown. Here, we report that focal adhesion kinase (FAK), as a critical downstream target of GRP-R, is an important regulator of neuroblastoma tumorigenicity. We found that FAK expression correlates with GRP-R expression in human neuroblastoma sections and cell lines. GRP-R overexpression in SK-N-SH cells increased FAK, integrin α3 and β1 expressions and cell migration. These cells demonstrated flatter cell morphology with broad lamellae, in which intense FAK expression was localized to the leading edges of lamellipodia. Interestingly, FAK activation was, in part, dependent on integrin α3 and β1 expression. Conversely, GRP-R silencing decreased FAK as well as Mycn levels in BE(2)-C cells, which displayed a denser cellular morphology. Importantly, rescue experiments in GRP-R silenced BE(2)-C cells showed FAK overexpression significantly enhanced cell viability and soft agar colony formation; similarly, FAK overexpression in SK-N-SH cells also resulted in increased cell growth. These effects were reversed in FAK silenced BE(2)-C cells in vitro as well as in vivo. Moreover, we evaluated the effect of FAK inhibition in vivo. FAK inhibitor (Y15) suppressed GRP-induced neuroblastoma growth and metastasis. Our results indicate that FAK is a critical downstream regulator of GRP-R, which mediates tumorigenesis and metastasis in neuroblastoma.
Insights
Focal adhesion kinase (FAK) is a key regulator of neuroblastoma growth and metastasis, acting downstream of the gastrin-releasing peptide receptor (GRP-R). Inhibiting FAK suppressed tumor progression, highlighting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Neuroblastomas exhibit elevated gastrin-releasing peptide receptor (GRP-R) levels.
- The precise molecular pathways linking GRP-R to neuroblastoma progression remain unclear.
Purpose of the Study:
- To investigate the role of focal adhesion kinase (FAK) as a downstream mediator of GRP-R signaling in neuroblastoma.
- To elucidate the mechanisms by which FAK influences neuroblastoma tumorigenicity and metastasis.
Main Methods:
- Correlative analysis of FAK and GRP-R expression in neuroblastoma tissues and cell lines.
- Manipulation of GRP-R and FAK expression (overexpression and silencing) in neuroblastoma cell lines (SK-N-SH, BE(2)-C).
- In vitro assays (cell viability, migration, soft agar colony formation) and in vivo studies using FAK inhibition (Y15).
Main Results:
- FAK expression positively correlated with GRP-R expression.
- GRP-R modulation affected FAK, integrin α3/β1, and Mycn levels, impacting cell morphology and migration.
- FAK overexpression enhanced neuroblastoma cell viability and growth, while FAK silencing reversed these effects.
- FAK inhibition significantly suppressed GRP-induced neuroblastoma growth and metastasis in vivo.
Conclusions:
- FAK is a critical downstream effector of GRP-R signaling in neuroblastoma.
- FAK plays a significant role in regulating neuroblastoma cell tumorigenicity, growth, and metastasis.
- Targeting FAK presents a potential therapeutic strategy for neuroblastoma treatment.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mitogens and the Cell Cycle
Negative Regulator Molecules
